Skip to content

Treatment of primary nonmetastatic melanoma at high-volume academic facilities is associated with improved long-term patient survival

22Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background: Previous studies of cancer care have demonstrated improved long-term patient outcomes for those treated at high-volume centers. The influence of treatment center characteristics on outcomes for primary nonmetastatic melanoma is not currently established. Objective: We aimed to investigate the association of cancer treatment center case volume and academic affiliation with long-term patient survival for cases of primary nonmetastatic melanoma. Methods: Cases of melanoma diagnosed in US adults from 2004 to 2014 and included in the National Cancer Database were identified. Hospitals were grouped by yearly case-volume quartile: bottom quartile, 2 middle quartiles, and top quartile. Results: Facility case volume was significantly associated with long-term patient survival (P

Cite

CITATION STYLE

APA

Cheraghlou, S., Agogo, G. O., & Girardi, M. (2019). Treatment of primary nonmetastatic melanoma at high-volume academic facilities is associated with improved long-term patient survival. Journal of the American Academy of Dermatology, 80(4), 979–989. https://doi.org/10.1016/j.jaad.2018.10.026

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free